FDA accepts Priority Review for MDMA capsules in PTSD treatment, based on Bessel van der Kolk's study.

Leading trauma psychiatrist Bessel van der Kolk's study shows potential for therapy-assisted MDMA to treat PTSD. MDMA, also known as ecstasy, has been linked to increased self-compassion and awareness in participants. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for MDMA capsules in combination with psychological intervention for PTSD treatment.

February 27, 2024
4 Articles